Toll-like receptor 4; hToll; CD284 (TLR4)
Jump to navigation
Jump to search
Function
- cooperates with LY96 & CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) or lipid A
- acts via MyD88, TIRAP & TRAF6
- NF-kappa-B activation
- cytokine secretion
- inflammatory response
- may attenuate allergic response[2]
- component of lipopolysaccharide receptor (LPS receptor)
- interacts with MyD88, TIRAP, NOX4
- interacts with LY96 via the extracellular domain
Structure
- N-glycosylated
- glycosylation of Asn-526 & Asn-575 appears to be necessary for the expression of TLR4 on the cell surface & the LPS-response
- mutants lacking 2 or more other N-glycosylation sites are deficient in interaction with LPS
- TIR domain mediates interaction with NOX4
- belongs to the Toll-like receptor family
- contains 21 LRR repeats (leucine-rich repeats)
- contains 1 TIR domain
Compartment
membrane
Alternative splicing
named isoforms=3
Expression
- expressed in placenta, spleen, peripheral blood leukocytes > monocytes, macrophages, dendritic cells, T-cells
Pathology
- genetic variation in TLR4 is associated with age-related macular degeneration type 10
Polymorphism
Pharmacology
- ibudilast inhibits Toll-like receptor 4 allegedly targeting neuroinflammation
- ApToll is a DNA oligonucleotide antagonist at toll-like receptor 4 & an investigational agent for treatment of ischemic stroke in combination with endovascular thrombectomy
More general terms
Additional terms
Component of
References
- ↑ Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=7099
- ↑ 2.0 2.1 Finn, PW UC San Diego